These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26071363)

  • 1. Mitochondrial energetic defects in muscle and brain of a Hmbs-/- mouse model of acute intermittent porphyria.
    Homedan C; Schmitt C; Laafi J; Gueguen N; Desquiret-Dumas V; Lenglet H; Karim Z; Gouya L; Deybach JC; Simard G; Puy H; Malthièry Y; Reynier P
    Hum Mol Genet; 2015 Sep; 24(17):5015-23. PubMed ID: 26071363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse model.
    Homedan C; Laafi J; Schmitt C; Gueguen N; Lefebvre T; Karim Z; Desquiret-Dumas V; Wetterwald C; Deybach JC; Gouya L; Puy H; Reynier P; Malthièry Y
    Int J Biochem Cell Biol; 2014 Jun; 51():93-101. PubMed ID: 24727425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hydroxymethylbilane synthase deficiency causes depression-like behavior and mitochondrial dysfunction in a mouse model of homozygous dominant acute intermittent porphyria.
    Berger S; Stattmann M; Cicvaric A; Monje FJ; Coiro P; Hotka M; Ricken G; Hainfellner J; Greber-Platzer S; Yasuda M; Desnick RJ; Pollak DD
    Acta Neuropathol Commun; 2020 Mar; 8(1):38. PubMed ID: 32197664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.
    Yasuda M; Gan L; Chen B; Yu C; Zhang J; Gama-Sosa MA; Pollak DD; Berger S; Phillips JD; Edelmann W; Desnick RJ
    Hum Mol Genet; 2019 Jun; 28(11):1755-1767. PubMed ID: 30615115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New mutations of the hydroxymethylbilane synthase gene in German patients with acute intermittent porphyria.
    Gross U; Puy H; Doss M; Robreau AM; Nordmann Y; Doss MO; Deybach JC
    Mol Cell Probes; 1999 Dec; 13(6):443-7. PubMed ID: 10657149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.
    Lindberg RL; Porcher C; Grandchamp B; Ledermann B; Bürki K; Brandner S; Aguzzi A; Meyer UA
    Nat Genet; 1996 Feb; 12(2):195-9. PubMed ID: 8563760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyria.
    Johansson A; Nowak G; Möller C; Harper P
    Mol Genet Metab; 2004 May; 82(1):20-6. PubMed ID: 15110317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement.
    Johansson A; Möller C; Fogh J; Harper P
    Mol Med; 2003; 9(9-12):193-9. PubMed ID: 15208740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria.
    Guillén-Navarro E; Carbonell P; Glover G; Sánchez-Solís M; Fernández-Barreiro A
    Ann Hum Genet; 2004 Sep; 68(Pt 5):509-14. PubMed ID: 15469427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria.
    Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI
    Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the hydroxymethylbilane synthase (HMBS) gene in Italian patients with acute intermittent porphyria: report of four novel mutations.
    Martinez di Montemuros F; Di Pierro E; Fargion S; Biolcati G; Griso D; Macrì A; Fiorelli G; Cappellini MD
    Hum Mutat; 2000 May; 15(5):480. PubMed ID: 10790212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Analysis of 55 Spanish Patients with Acute Intermittent Porphyria.
    Morán-Jiménez MJ; Borrero-Corte MJ; Jara-Rubio F; García-Pastor I; Díaz-Díaz S; Castelbón-Fernandez FJ; Enríquez-de-Salamanca R; Méndez M
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria.
    Johansson A; Nowak G; Möller C; Blomberg P; Harper P
    Mol Ther; 2004 Aug; 10(2):337-43. PubMed ID: 15294180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.
    Dixon N; Li T; Marion B; Faust D; Dozier S; Molina A; Rudnick S; Bonkovsky HL
    Mol Genet Metab; 2019 Nov; 128(3):228-235. PubMed ID: 31153822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs.
    Ruspini SF; Zuccoli JR; Lavandera JV; Martínez MDC; Oliveri LM; Gerez EN; Batlle AMDC; Buzaleh AM
    Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1296-1305. PubMed ID: 29476795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxymethylbilane synthase gene mutations and polymorphisms in Brazilian families with acute intermittent porphyria.
    Gonzaga AD; de Amorim LM; Fonseca AB; Nogueira TL; Pereira OM; Nagai MA; de Oliveira Barretto OC; Ribeiro GS
    Ann Hum Genet; 2015 May; 79(3):162-72. PubMed ID: 25703257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the hepatic transcriptome following phenobarbital induction in mice with AIP.
    Chen B; Wang M; Gan L; Zhang B; Desnick RJ; Yasuda M
    Mol Genet Metab; 2019 Nov; 128(3):382-390. PubMed ID: 30777612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma.
    Molina L; Zhu J; Trépo E; Bayard Q; Amaddeo G; ; Blanc JF; Calderaro J; Ma X; Zucman-Rossi J; Letouzé E
    J Hepatol; 2022 Oct; 77(4):1038-1046. PubMed ID: 35636578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias.
    Schneider-Yin X; van Tuyll van Serooskerken AM; Siegesmund M; Went P; Barman-Aksözen J; Bladergroen RS; Komminoth P; Cloots RH; Winnepenninckx VJ; zur Hausen A; Weber M; Driessen A; Poblete-Gutiérrez P; Bauer P; Schroeder C; van Geel M; Minder EI; Frank J
    J Hepatol; 2015 Mar; 62(3):734-8. PubMed ID: 25445397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel heterozygous mutation in the HMBS gene in a patient with acute intermittent porphyria and posterior reversible encephalopathy syndrome.
    Yang Y; Chen X; Wu H; Peng H; Sun W; He B; Yuan Z
    Mol Med Rep; 2020 Jul; 22(1):516-524. PubMed ID: 32377710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.